Targeting VEGF-A in an Immunocompetent Orthotopic Mouse Model of Mesenchymal Glioblastoma Improves Antitumorigenicity and Decreases Proinflammatory Response in Normal Brain Tissue after Fractionated Radiotherapy

Nieto, Alexander Edward; Fleischmann, Daniel Felix; Unger, Kristian; Albrecht, Valerie; Maas, Jessica; Zitzelsberger, Horst; Belka, Claus; Proescholdt, Martin; Lauber, Kirsten; Niyazi, Maximilian; Orth, Michael

dc.contributor.author	Niyazi, Maximilian
dc.contributor.author	Orth, Michael
dc.date.accessioned	2026-02-02T07:24:38Z
dc.date.available	2026-02-02T07:24:38Z
dc.date.issued	2025
dc.identifier.issn	2366-3987
dc.identifier.uri	http://hdl.handle.net/10900/174530
dc.language.iso	en	de_DE
dc.publisher	Hoboken : Wiley	de_DE
dc.relation.uri	http://dx.doi.org/10.1002/adtp.202400374	de_DE
dc.subject.ddc	610	de_DE
dc.title	Targeting VEGF-A in an Immunocompetent Orthotopic Mouse Model of Mesenchymal Glioblastoma Improves Antitumorigenicity and Decreases Proinflammatory Response in Normal Brain Tissue after Fractionated Radiotherapy	de_DE
dc.type	Article	de_DE
utue.quellen.id	20250630000000_02015
utue.personen.roh	Nieto, Alexander Edward
utue.personen.roh	Fleischmann, Daniel Felix
utue.personen.roh	Unger, Kristian
utue.personen.roh	Albrecht, Valerie
utue.personen.roh	Maas, Jessica
utue.personen.roh	Zitzelsberger, Horst
utue.personen.roh	Belka, Claus
utue.personen.roh	Proescholdt, Martin
utue.personen.roh	Lauber, Kirsten
utue.personen.roh	Niyazi, Maximilian
utue.personen.roh	Orth, Michael
dcterms.isPartOf.ZSTitelID	Advanced Therapeutics	de_DE
dcterms.isPartOf.ZS-Issue	Article 2400374	de_DE
dcterms.isPartOf.ZS-Volume	8 (2)	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE